Vector Borne Illnesses - PowerPoint PPT Presentation

1 / 56
About This Presentation
Title:

Vector Borne Illnesses

Description:

Vector Borne Illnesses By Bryan E. Mosora, DO – PowerPoint PPT presentation

Number of Views:187
Avg rating:3.0/5.0
Slides: 57
Provided by: laur4248
Category:

less

Transcript and Presenter's Notes

Title: Vector Borne Illnesses


1
Vector Borne Illnesses
  • By
  • Bryan E. Mosora, DO

2
Objectives
  • Attendees will
  • Recognize disease associated with the common
    vector involved
  • Compare vector borne illnesses
  • Demonstrate capability to council travelers to
    decrease risk of contracting a disease

3
Uh Oh, What is this!
4
What are they?
  • African Trypanosomiasis
  • Babesiosis
  • Chagas Disease
  • Dengue Fever
  • Ehrlichiosi
  • Leishmaniasis
  • Lyme Disease
  • Lymphatic Filariasis
  • Trypanosomiasis
  • Tularemia
  • Typhus
  • Malaria
  • Onchocerciasis
  • Plague
  • Q Fever
  • Relapsing Fever
  • Rickettsia
  • Rocky Mountain Spotted Fever
  • Southern Tick-Associated Rash Illness
  • Trachoma
  • West Nile Virus
  • Yellow Fever

5
Vector Bone Diseases
  • defined as the diseases, mostly parasitic, which
    are commonly transmitted through vectors.
  • "Vector" is a term used broadly to refer to any
    animal that can transmit human disease or plays
    an essential role in the parasites life cycle.

6
Be careful what you catch!!!!
7
Real Problem for Us?
  • According to the CDC, vector borne diseases are
    steadily on the rise.
  • Due to ease of travel
  • eco type vacation surge
  • Lack of knowledge on patient and practitioners
    part.

8
African trypanosomiasis
  • also known as sleeping sickness
  • protozoan parasites (two kinds specific to
    location) are both transmitted by the tsetse fly
  • Diagnosis of the disease should correlate with
    appropriate history of exposure due to limited
    geographical predominance.

9
African trypanosomiasis
10
African trypanosomiasis
  • A definitive diagnosis of infection requires the
    demonstration of the parasite, usually from the
    blood, lymph node aspirate or cerebrospinal fluid
    (CSF) on microscopy.
  • Only research tools such as isoenzyme analysis
    and restriction fragment length polymorphism
    (RFLP) are available for a definitive subspecies
    identification.
  • The organisms can be visualized in blood smears,
    lymph node aspirates, and CSF.

11
African Trypanosomiasis
African Trypanosomiasis
12
Tsetse Fly
13
African trypanosomiasis
  • Thick smears of peripheral blood stained with
    Giemsa or direct thin smear preparations may show
    trypanosomes
  • sensitivity of blood smears varies with the stage
    of disease and the infecting species.
  • Smears are more likely to be positive in early
    stages of infection when there are high numbers
    of circulating parasites

14
Trypanosomiasis
15
Trypanosoma brucei
16
African trypanosomiasis
  • All treatment regimens involve toxic or expensive
    drugs that are cumbersome to administer, and it
    is estimated that between three and five percent
    of those treated in the late stage of infection
    die from side effects of the treatment itself.
  • Examination of the CSF is mandatory whenever the
    diagnosis is suspected, both to help confirm the
    diagnosis and to stage the infection.

17
Treatment options
  • Pentamidine
  • Suramin
  • Melarsoprol
  • Eflornithine

18
American trypanosomiasis
  • AKA Chagas Disease
  • caused by the protozoan parasite Trypanosoma
    cruzi
  • The vector is the reduviid bug, also known as the
    "kissing bug".
  • found only in Central and South America, Mexico
    and the southern United States.

19
Kissing Bug
20
Chagas' disease
  • When the vector takes a blood meal, it defecates
    around the bite site.
  • The resulting irritation causes the host to
    scratch
  • Humans are characteristically bitten on the face
    at night while sleeping (kissing bug)
  • inoculation of parasites can occur via breaks in
    the skin or directly into mucous membranes or
    into conjunctivae

21
Chagas' disease
  • The pathogenesis of chronic Chagas' disease is
    unclear.
  • extensive debate over whether complications are
    due directly to parasite invasion or to secondary
    autoimmune mechanisms
  • Organs involved in disease show chronic
    inflammatory changes and diffuse fibrosis.
  • The conduction system and the muscle are affected
    in the heart.
  • In the GI tract, loss of neurons, inflammation
    and fibrosis of the gut wall develop.

22
Chagas' disease
  • The major morbidity associated with this disease
    is threefold cardiac disease, megaesophagus, and
    megacolon.
  • Cardiac involvement is characterized by
    myocarditis and ultimately a dilated
    cardiomyopathy that becomes evident years after
    infection.

23
Chagas' disease
  • Many individuals do not experience any symptoms
    and are unaware that they have been infected.
  • The typical features of acute symptomatic
    infection are fever, swollen face or eyelids
    (Romana's sign), peripheral edema,
    conjunctivitis, hepatosplenomegaly, and
    lymphadenopathy.

24
Romana's sign
25
Megacolon
26
Megaesophagus
  • The most common symptom in megaesophagus is
    dysphagia.
  • There can be associated discomfort and pain that
    typically starts in the lower substernal area and
    radiates superiorly.
  • food may become lodged in the esophagus and cause
    local irritation, leading to inflammation,
    ulceration, bleeding, perforation and fistulas.
  • Regurgitation of ingested food can also occur
  • Patients with megaesophagus are at increased risk
    for esophageal cancer

27
Megacolon
  • Involvement of the colon leads to abnormal basal
    colonic motility and an impaired relaxation
    response in the anal sphincter.
  • The typical presenting symptom is constipation.
    patients may go for weeks without being able to
    pass stool.
  • Progressive colicky abdominal pain frequently
    develops.
  • Physical examination often reveals a tympanitic
    abdomen and an easily palpable colon.
  • Anorexia and malnutrition can also develop.

28
Treatment
  • The goals of medical care in those with Chagas
    disease are to eliminate the parasites
    (etiological treatment) and to correct the damage
    caused by the parasites.
  • The only available drug with some activity
    against T cruzi that is tolerated in humans is
    benznidazole.
  • The failure of treatment in the 30-40 of other
    patients may be related to parasite resistance to
    benznidazole, the intensity of parasitism, or
    other unknown reasons.
  • The medical treatment of chronic heart chagasic
    disease is similar to that for other
    cardiomyopathies.

29
Treatment
  • Most patients, particularly those with
    ventricular tachycardia associated with
    myocardial dysfunction, may benefit from the use
    of class III antiarrhythmic drugs (sotalol and
    amiodarone).
  • Patients in stages II and III of chagasic
    megaesophagus can be relieved by a dilatation of
    the esophagogastric sphincter using extensible
    balloons. surgical treatment is preferable.
  • In chagasic megacolon, patients with moderate
    constipation or those in whom surgery is
    unsuitable may benefit from lubricant laxatives
    (paraffin oil) or drugs that stimulate colon
    mobility and a water-glycerol (101 ratio) enema.

30
Malaria
  • Human malaria is caused by four species of
    Plasmodia P. falciparum, P. vivax, P. ovale, and
    P. malariae.
  • The majority of malaria infection is caused by
    either P. falciparum or P. vivax, and most
    malaria-associated deaths are due to P.
    falciparum
  • Increased incidence over past several years

31
Malaria
  • Increasing resistance of malarial parasites to
    chemotherapy
  • Increasing resistance of the Anopheles mosquito
    vector to insecticides
  • Ecologic and climate changes
  • Increased international travel to malaria-endemic
    areas

32
Malaria
33
Malaria
  • Approximately 300 to 500 million cases of malaria
    and 700,000 to 2.7 million deaths occur annually
    worldwide
  • Approximately 30,000 travelers from
    industrialized countries contract malaria each
    year

34
Risk By Region
  • Oceania 130 or higher
  • Sub-Saharan Africa 150
  • Indian subcontinent 1250
  • Southeast Asia 11,000
  • South America 12,500
  • Central America 110,000

35
Oceania
36
Malaria
  • During 2004, the Centers for Disease Control and
    Prevention received 1324 reports of cases of
    malaria in the United States, including four
    fatal cases
  • Malaria transmission is predominantly via the
    bite of a female Anopheles sp. Mosquito
  • Species of Anopheles mosquitoes are seasonally
    present in all states of the United States,
    except Hawaii
  • In addition, "airport malaria" can occur when
    infected mosquitoes enter the country by aircraft
    and then transmit the infection.

37
Malaria
38
Malaria
  • All four malaria parasite species digest red cell
    proteins and hemoglobin.
  • The parasites derive energy from anaerobic
    glycolysis of glucose to lactic acid, which can
    cause hypoglycemia and lactic acidosis.
  • The parasites also alter the red cell membrane,

39
Malaria
40
Malaria
  • P. falciparum has additional unique
    characteristics that help to explain its distinct
    potential to cause severe or fatal disease.
  • As falciparum parasites mature within red blood
    cells, they induce the formation of sticky knobs
    on the surface of erythrocytes
  • results in obstruction to blood flow.

41
Malaria
  • The signs and symptoms of malaria are varied, but
    virtually all nonimmune individuals will
    experience fever.
  • Other frequent symptoms include chills, sweats,
    headache, myalgias, fatigue, nausea, abdominal
    pain, vomiting, diarrhea and cough.
  • .Early in malarial infections, especially with P.
    falciparum, febrile paroxysms often are daily and
    irregular.
  • Anemia, thrombocytopenia, splenomegaly,
    hepatomegaly and jaundice can develop, and
    splenic rupture can occasionally occur

42
Malaria
  • The diagnosis of malaria should be considered in
    any febrile individual who has traveled to or
    resided in a malarious region, even if briefly or
    only in transit.
  • Moreover, the diagnosis should be considered in
    others with fevers of unknown origin even if
    there is no known geographic exposure

43
Malaria
  • The conventional method for diagnosing malaria is
    light microscopy of a Giemsa-stained thick and/or
    thin blood smear
  • Because of the cyclical nature of the
    parasitemia, smears should be taken every 6 to 12
    hours for 48 hours before the diagnosis of
    malaria is ruled out,
  • first smear is positive in 95 percent of cases

44
Malaria
  • Travelers to malarious regions should receive
    from their physician or travel clinic advice
    about malaria
  • Guidance on mosquito avoidance
  • Prescriptions for appropriate chemoprophylactic
    medications
  • Failure to comply with chemoprophylactic
    medication schedules can contribute to morbidity
    and death in travelers

45
Malaria
  • Mosquito avoidance
  • Remaining in screened areas whenever possible
  • Using mosquito netting, ideally treated with
    Covering exposed skin with clothing
  • Applying insect repellent
  • Clothing and bed netting can be treated with
    permethrin for protection against mosquitoes and
    ticks
  • A number of drugs are available for use in
    malaria prevention, including chloroquine,
    metloquine, Malarone doxycycline, proguanil,
    primaquine, and Fansidar

46
Malaria
  • PROPHYLAXIS AGAINST CHLOROQUINE-RESISTANT
    FALCIPARUM MALARIA
  • The incidence of chloroquine-resistant falciparum
    malaria varies according to the location visited.
  • CDC website is updated frequently to highlight
    known resistance areas

47
Lyme Disease
  • Lyme disease is caused by the bacterium Borrellia
    burgdorferi and is transmitted to humans by the
    bite of infected blacklegged ticks.
  • Typical symptoms include fever, headache,
    fatigue, and a characteristic skin rash called
    erythema migrans

48
Tick
49
Lyme disease
50
Erythema Migrans
51
Lyme Disease
  • early disseminated Lyme disease, is when the
    infection of bacteria is beginning to spread and
    is affecting certain body functions.
  • This stage occurs weeks to months after the bite
    of an infected tick.
  • Numbness and pain in arms or legs
  • Paralysis of facial muscles (usually on one side
    of the face)
  • Meningitisfever, stiff neck, and severe
    headaches
  • Abnormal heart beat (rare)

52
Lyme Disease
  • late (or chronic) Lyme disease can occur weeks,
    months, or even years after infection in patients
    who either never received antibiotic treatment
    for early Lyme disease or whose treatment did not
    kill all of the bacteria that cause Lyme disease.
  • Chronic Lyme arthritis
  • Nervous system problems, including memory loss
    and difficulty concentrating
  • Chronic pain in muscles

53
Lyme Disease
  • Blood tests, also known as Lyme titers, cannot
    diagnose Lyme disease alone, but they are used to
    confirm a diagnosis.
  • The most common blood test ordered for Lyme
    disease is the ELISA, with the western blot used
    as a follow-up test.
  • Other bacterial infections and diseases may cause
    an ELISA to be positive
  • the Western Blot, a more accurate test that can
    be used 6 to 12 weeks after infection and is
    recommended to confirm all positive or equivocal
    ELISA results.
  • Treatment should be started if high clinical
    suspicion in light of the tests

54
Treatment
  • Oral antibiotics (eg, amoxicillin, doxycycline,
    cefuroxime axetil, erythromycin, azithromycin,
    amoxicillin-clavulanate) should be administered
    for 10-30 days with an average of 3 weeks
  • Early disseminated disease findings may be
    treated with oral antibiotics for 21-30 days.
  • meningitis or a high-degree heart block may be
    treated with intravenous ceftriaxone for 2-4
    weeks. Occasionally, prednisone may hasten
    resolution of the conduction defect
  • Arthritis may be treated with oral antibiotics
    for 30-60 days, and intravenous ceftriaxone may
    be administered for coexistent neurologic
    disease.

55
And in conclusion!!!!!
  • Many other vector borne illnesses exist
  • CDC maintains an extensive library of these
    illnesses and there common geographic localities
  • Use resources such as the internet for quick info
    for patients who will be traveling to endemic
    areas

56
Questions?????
Write a Comment
User Comments (0)
About PowerShow.com